Novo Nordisk has faced a massive selloff in recent months amid disappointing drug trials and U.S. pressure to cut its prices.

These are some of Trump’s words. What really comes first, and we’re already getting a taste of it, is that Trump and his oligarch sidekicks come first. The naïve and ...

Viking Therapeutics investors face challenges as stock plummets, cash runway helps but betting on early stage biopharma ...

EWTN News, Inc. is the world’s largest Catholic news organization, comprised of television, radio, print and digital media ...

Fact check: Peace through strength is a concept touted by many leaders throughout history, starting with the Roman Empire Hadrian over 2,000 years ago, including Presidents George Washington and ...

January 20, 2025 (Washington D.C.) – Donald J. Trump was sworn in for his second term of office today inside the Capitol rotunda, instead of outdoors, due to bitterly cold weather. In a 30-minute ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

In a report released today, James Quigley from Goldman Sachs maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price ...

An observational study has uncovered a possible link between taking GLP-1s and increased risk of kidney, pancreas and gut ...